Relinquish-M (Artemisinin/Piperaquine)
| Active Ingredient | Artemisinin/Piperaquine |
|---|---|
| Manufacturers | Kachhela Medex Pvt. Ltd. |
| Indications | Malaria |
| Strength | 62.5mg+375mg |
| Packaging | 4 Tablets in 1 Strip |
| Delivery Time | 6 To 15 days |
Relinquish‑M is an effective combination therapy containing Artemisinin and Piperaquine, formulated to treat uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax. The fast-acting artemisinin component rapidly reduces the parasite load within 24–48 hours, while piperaquine provides a longer half-life to clear residual parasites and prevent early recurrence. This once‑daily oral treatment is typically taken for three consecutive days, ideally under medical supervision, ensuring compliance and monitoring for safety.








There are no reviews yet.